Call Options Transactions Made in Q4 2023 in Direxion Daily S&P Biotech Bea (LABD)
This table provides information about the institutional ownership of Direxion Daily S&P Biotech Bea (LABD) during Q4 2023. The information is specifically focused on institutions that hold call options of DIREXION DAILY S&P BIOTECH BEA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 18, 2024
Q4 2023
|
Cutler Group LP
|
BUY
|
CALL |
146K+ 333.94% |
$1.34M - $4.29M
|
189K
$1.04M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
135K+ 47.52% |
$1.24M - $3.98M
|
419K
$2.31M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
69.7K+ 12.76% |
$641K - $2.05M
|
616K
$3.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
19.1K+ 35.3% |
$176K - $563K
|
73.2K
$404K
|
|
|
Feb 14, 2024
Q4 2023
|
Hap Trading, LLC
New York, NY |
BUY
|
CALL |
10.8KNew |
$99.4K - $318K
|
10.8K
$59.6K
|